Vetter Receives Internationally Recognized AEO-F Certificate
News Dec 02, 2015
Vetter has received the status of Authorized Economic Operator Full (AEO-F) from the European Union confirming Vetter reliability, solvency, and high safety standards in international trade. Vetter’s customers worldwide will now benefit from shorter transit times and lower costs with the usual high product quality.
The internationally accepted AEO-F certification (Authorized Economic Operator - Customs simplifications/Security) will facilitate the import of drugs in third countries. The certificate confirms the compliance of high safety requirements throughout the entire supply chain of a company.
Customs procedures of consignments will be simplified and accelerated, all of which results in shortened transport durations, as well as improved fulfillment of pharmaceutical requirements for transit times. Another advantage is the facilitation of regulatory proceedings for security reviews and audits. Thus, Vetter and its customers benefit from additional time and cost savings in international supply chains.
"With the recognition afforded by the granting of the AEO-F certificate, we can enable our customers not only a fast and smooth international customs clearance, but more importantly, a very high standard of safety,” said Carsten Press, Senior Vice President Supply Chain Management. “The certification is important for Vetter, and at the same time, it is also further evidence of the high service and product quality we offer to our customers.” With the extended certificate, the benefits of the previous AEO-C status for the European movement of goods also apply at the global level.
The AEO-F certificate is currently accepted by the US and Japan, the EU Member States, Switzerland, Norway and China. The aim of the World Customs Organization is to continue to expand the agreement to additional countries.
By expanding the Authorized Economic Operator (AEO) concept, they will establish a uniform customs and security standard in the international movement of goods within the framework of the SAFE (Standards to Secure and Facilitate Global Trade) program. The European Union commends the recognition of the concept in international agreements with third countries in order to protect the supply chain from manufacturers to end users.
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in TexasNews
First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.READ MORE
IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE AntibodiesNews
The project will add to IGEM’s pipeline of drugs and expand upon IGEM-F, an IgE targeting ovarian and other cancers, currently in a Phase 1/2a study.READ MORE
Comments | 0 ADD COMMENT
15th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry
Sep 09 - Sep 12, 2018
CE in the Biotechnology & Pharmaceutical Industries: 20th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides & Small Molecules
Sep 09 - Sep 12, 2018